glp-1 bowel obstruction Severe Small-Bowel in a High-Risk Patient on Long-Term Tirzepatide Therapy: A Case Report Gastrointestinal Adverse Effects of GLP-1
Description
Incretins: B eyond type 2 diabetes
Attach Supporting Documentation : Ensure that all pertinent medical records, lab results, or clinical notes that strengthen the case for authorization are attached
Always involve your prescribing physician in any decision to pause medication
eligibility is determined through your provider and plan
Growing evidence is building on the efficacy of GLP-1 RAs in NAFLD
